AP

Ankineedu Prasad Anil Kumar Gogineni

Active Director Director DIN 11446866
DIN 11446866 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ankineedu Prasad Anil Kumar Gogineni

Data last updated:

Ankineedu Prasad Anil Kumar Gogineni is a Director at Globalmedix Pharma Exports Private Limited (since 2025).

DIN 11446866
Primary Designation Director
First Appointment 23 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Dec 20252025Active

Board colleagues of Ankineedu Prasad Anil Kumar Gogineni

NameDINCompanyDesignation
Ravikanth Kollipara08115857Globalmedix Pharma Exports Private LimitedDirector

Directorship timeline

Open interactive timeline →
Globalmedix Pharma Exports Private Limited
Premium access

Shareholding and investment profile for Ankineedu Prasad Anil Kumar Gogineni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankineedu Prasad Anil Kumar Gogineni

Ankineedu Prasad Anil Kumar Gogineni currently holds 1 directorship: Globalmedix Pharma Exports Private Limited (Director, since 23 Dec 2025).

Ankineedu Prasad Anil Kumar Gogineni was first appointed on 23 Dec 2025 as Director at Globalmedix Pharma Exports Private Limited.

The current boards of Ankineedu Prasad Anil Kumar Gogineni's companies include Ravikanth Kollipara (Globalmedix Pharma Exports Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available